Gene: DENND3
Official Full Name: DENN domain containing 3provided by HGNC
Gene Summary: Enables guanyl-nucleotide exchange factor activity. Predicted to be involved in endosome to lysosome transport; protein catabolic process; and regulation of Rab protein signal transduction. Predicted to be located in cytosol. Predicted to be active in cytoplasmic vesicle. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30184 | DENND3 Knockout cell line (HeLa) | Human | DENND3 | 1:3~1:6 | Negative | Online Inquiry |
KO30185 | DENND3 Knockout cell line (HCT 116) | Human | DENND3 | 1:2~1:4 | Negative | Online Inquiry |
KO30186 | DENND3 Knockout cell line (HEK293) | Human | DENND3 | 1:3~1:6 | Negative | Online Inquiry |
KO30187 | DENND3 Knockout cell line (A549) | Human | DENND3 | 1:3~1:4 | Negative | Online Inquiry |
DENND3 Gene Knockout Cell Lines are specialized cellular models developed to facilitate the study of the DENND3 gene, known for its role in cellular processes such as endocytosis and membrane trafficking. These knockout cell lines are engineered using CRISPR-Cas9 technology, which allows for precise gene editing, resulting in the complete disruption of the DENND3 gene expression. By eliminating the function of this gene, researchers gain critical insight into its physiological roles and implications in various diseases, including cancer and metabolic disorders.
The primary mechanism by which DENND3 gene knockout exerts its effects is through the loss of specific protein interactions and pathways that DENND3 regulates. This disruption can lead to altered cellular behaviors, including changes in cellular signaling, trafficking dynamics, and response to external stimuli. Such models enable researchers to dissect the complex biological networks that involve DENND3, ultimately elucidating its contribution to pathological states and providing a platform for therapeutic discovery.
The scientific importance of DENND3 Gene Knockout Cell Lines extends to both basic research and clinical applications. These cell lines can be instrumental in drug discovery, allowing for high-throughput screening of therapeutic agents targeting pathways influenced by DENND3. Furthermore, they provide a valuable resource for studying gene function and regulatory mechanisms in human diseases, bridging the gap between fundamental biology and clinical therapeutics.
What sets DENND3 Gene Knockout Cell Lines apart from other cell models is their unparalleled specificity and reliability. Unlike generalized knockdown approaches that may lead to incomplete gene suppression, our knockout technology ensures a complete and reproducible gene disruption. This precision allows researchers to confidently attribute observed biological effects to the loss of DENND3 function.
For researchers and clinicians seeking to push the boundaries of understanding gene function, DENND3 Gene Knockout Cell Lines offer a robust tool that enhances experimental rigor and unlocks new avenues for discovery. Our company, recognized for its commitment to cutting-edge genetic technologies, provides high-quality, validated knockout cell lines that exemplify our dedication to supporting the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.